Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Ocular Therapeutix, Inc. | OCUL | 12.54M | $123.14M |
Arrowhead Pharmaceuticals, Inc. | ARWR | 11.36M | $925.59M |
Kymera Therapeutics, Inc. | KYMR | 7.47M | $857.13M |
Definium Therapeutics, Inc. | DFTX | 7.19M | $338.17M |
uniQure N.V. | QURE | 6.73M | $309.88M |
Xenon Pharmaceuticals Inc. | XENE | 5.78M | $348.75M |
Vera Therapeutics, Inc. | VERA | 5.72M | $245.61M |
Ascendis Pharma A/S | ASND | 5.11M | $1.36B |
Cytokinetics, Incorporated | CYTK | 5M | $425.95M |
Celcuity Inc. | CELC | 3.4M | $355.71M |
Krystal Biotech, Inc. | KRYS | 2.89M | $1.07B |
United Therapeutics Corporation | UTHR | 2.78M | $1.51B |
Viridian Therapeutics, Inc. | VRDN | 2.5M | $45.92M |
Revolution Medicines, Inc. | RVMD | 2.3M | $430.18M |
Hemab Therapeutics Holdings, Inc. Common Stock | COAG | 1.93M | $70.71M |
Madrigal Pharmaceuticals, Inc. | MDGL | 1.83M | $984.41M |
Septerna Inc | SEPN | 1.34M | $44.79M |
argenx SE | ARGX | 1M | $927.77M |